Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement

Locally advanced or metastatic cholangiocarcinoma is an aggressive carcinoma with a dismal prognosis. For the first-line treatment of locally advanced or metastatic cholangiocarcinoma, cisplatin/gemcitabine has been the standard of care for more than 10 years. Its combination with the immune checkpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh, Hossein, Djanani, Angela, Eisterer, Wolfgang, Gerger, Armin, Gruenberger, Birgit, Gruenberger, Thomas, Rumpold, Holger, Weiss, Lukas, Winder, Thomas, Wöll, Ewald, Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499516/
https://www.ncbi.nlm.nih.gov/pubmed/37711201
http://dx.doi.org/10.3389/fonc.2023.1225154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499516/
https://www.ncbi.nlm.nih.gov/pubmed/37711201
http://dx.doi.org/10.3389/fonc.2023.1225154

Ejemplares similares